Modulating the hypoxia-inducible factor signaling pathway: applications from cardiovascular disease to cancer

KS Hewitson, LA McNeill… - Current pharmaceutical …, 2004 - ingentaconnect.com
Humans, like other complex aerobic organisms, possess highly evolved systems for the
delivery of dioxygen to all the cells of the body. These systems are regulated since …

Hypoxia-induced signaling in the cardiovascular system

MC Simon, L Liu, BC Barnhart, RM Young - Annu. Rev. Physiol., 2008 - annualreviews.org
Low oxygen (O2) levels are a naturally occurring feature of embryonic development, adult
physiology, and diseases such as those of the cardiovascular system. Although many …

HIF-1: structure, biology and natural modulators

Y Chao, ZF Zhong, W Sheng-Peng, V Chi-Teng… - Chinese Journal of …, 2021 - Elsevier
Abstract Hypoxia-inducible factor 1 (HIF-1), as a main transcriptional regulator of metabolic
adaptation to changes in the oxygen environment, participates in many physiological and …

HIF in the heart: development, metabolism, ischemia, and atherosclerosis

AK Knutson, AL Williams, WA Boisvert… - The Journal of …, 2021 - Am Soc Clin Investig
The heart forms early in development and delivers oxygenated blood to the rest of the
embryo. After birth, the heart requires kilograms of ATP each day to support contractility for …

HIF-1 as a target for drug development

A Giaccia, BG Siim, RS Johnson - Nature reviews Drug discovery, 2003 - nature.com
Sensing and responding to fluxes in oxygen tension is perhaps the single most important
variable in physiology, and animal tissues have developed a number of essential …

Targeting hypoxia-inducible factors: therapeutic opportunities and challenges

X Yuan, W Ruan, B Bobrow, P Carmeliet… - Nature Reviews Drug …, 2024 - nature.com
Hypoxia-inducible factors (HIFs) are highly conserved transcription factors that are crucial for
adaptation of metazoans to limited oxygen availability. Recently, HIF activation and …

The interplay of hypoxia signaling on mitochondrial dysfunction and inflammation in cardiovascular diseases and cancer: from molecular mechanisms to therapeutic …

E Bouhamida, G Morciano, M Perrone, AE Kahsay… - Biology, 2022 - mdpi.com
Simple Summary The regulation of hypoxia has recently emerged as having a central impact
in mitochondrial function and dysfunction in various diseases, including the major disorders …

Keeping the engine primed: HIF factors as key regulators of cardiac metabolism and angiogenesis during ischemia

RV Shohet, JA Garcia - Journal of Molecular Medicine, 2007 - Springer
Myocardial ischemia, the most common cause of cardiac hypoxia in clinical medicine,
occurs when oxygen delivery cannot meet myocardial metabolic requirements in the heart …

Hypoxia inducible factor as a therapeutic target for atherosclerosis

T Jain, EA Nikolopoulou, Q Xu, A Qu - Pharmacology & therapeutics, 2018 - Elsevier
Atherosclerosis is a highly prevalent disease that can significantly increase the risk of major
vascular events, such as myocardial or cerebral infarctions. The anoxemia theory states that …

Hypoxia-inducible factor 3 biology: complexities and emerging themes

C Duan - American Journal of Physiology-Cell Physiology, 2016 - journals.physiology.org
The hypoxia-inducible factor (HIF) family has three distinct members in most vertebrates. All
three HIFs consist of a unique and oxygen-labile α-subunit and a common and stable β …